Actively Recruiting
Breast Cancer Risk From Sonographic Glandular Tissue Component (or International GTC Study)
Led by Seoul National University Hospital · Updated on 2024-06-04
16164
Participants Needed
1
Research Sites
478 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
An international multicenter study to prospectively validate the association between sonographic GTC and subsequent breast cancer risk in women with dense breasts.
CONDITIONS
Official Title
Breast Cancer Risk From Sonographic Glandular Tissue Component (or International GTC Study)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Be between 40 and 69 years old at the time of ultrasound
- No history of previous breast cancer including ductal carcinoma in situ (DCIS)
- Have dense breasts (BI-RADS category C or D) on mammography done within 12 months before breast ultrasound
- Have a negative or benign mammogram assessment (BI-RADS 1 or 2)
- Undergoing screening breast ultrasound using either an automated or handheld device
You will not qualify if you...
- History of bilateral prophylactic mastectomy
- History of bilateral foreign body injection
- History of bilateral breast implants
- History of bilateral breast reduction surgery or surgical excision
- Currently pregnant or breastfeeding within the past 6 months
- Known distant metastasis from another primary cancer
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Seoul National University Hospital
Seoul, South Korea
Actively Recruiting
Research Team
W
Woo Kyung Moon, MD, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here